DISEASE INDICATIONS: Breast Cancer
MANUFACTURER: Roche Registration Limited
USAGE: Intravenous
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Health Canada
Therapeutic Goods Administration (TGA)
Medsafe (NZ)
Perjeta (Pertuzumab) is a monoclonal antibody medication used for treating specific types of breast cancer that overexpress the HER2 protein. It works by binding to the HER2 protein, preventing cancer cell growth and promoting cell death.